Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coupang
CPNG
|
+$1.83B |
| 2 |
Roblox
RBLX
|
+$1.63B |
| 3 |
BILL Holdings
BILL
|
+$1.46B |
| 4 |
Airbnb
ABNB
|
+$774M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$620M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$2.32B |
| 2 |
Spotify
SPOT
|
+$1.39B |
| 3 |
Okta
OKTA
|
+$1.24B |
| 4 |
Alibaba
BABA
|
+$1.16B |
| 5 |
Amazon
AMZN
|
+$1.05B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.4% |
| 2 | Healthcare | 9.82% |
| 3 | Financials | 9.22% |
| 4 | Consumer Discretionary | 8.85% |
| 5 | Communication Services | 8.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JRO
2501
DELISTED
Nuveen Floating Rate Income Opportunty Fund
JRO
| $14M | ﹤0.01% |
1,401,521
+147,319
| +12% | +$1.44M |
|
|
GES
2502
DELISTED
Guess Inc
GES
| $14M | ﹤0.01% |
664,967
+99,759
| +18% | +$2.28M |
|
2503
Sturm, Ruger & Co
RGR
$625M
| $13.9M | ﹤0.01% |
188,666
-100,868
| -35% | -$7.84M |
|
2504
Vericel Corp
VCEL
$2.37B
| $13.9M | ﹤0.01% |
285,037
-12,699
| -4% | -$657K |
|
2505
Neurocrine Biosciences
NBIX
$16.9B
| $13.9M | ﹤0.01% |
144,891
-204,709
| -59% | -$19.3M |
|
2506
ProShares High Yield-Interest Rate Hedged ETF
HYHG
$186M
| $13.9M | ﹤0.01% |
220,357
+19,806
| +10% | +$1.24M |
|
|
HIBB
2507
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $13.9M | ﹤0.01% |
196,098
+17,528
| +10% | +$1.53M |
|
2508
Invesco China Technology ETF
CQQQ
$3.14B
| $13.9M | ﹤0.01% |
210,867
-135,144
| -39% | -$9.66M |
|
|
EPZM
2509
DELISTED
Epizyme, Inc
EPZM
| $13.9M | ﹤0.01% |
2,708,473
+684,721
| +34% | +$4.16M |
|
2510
iShares Agency Bond ETF
AGZ
$564M
| $13.9M | ﹤0.01% |
117,036
+28,071
| +32% | +$3.34M |
|
|
BPMC
2511
DELISTED
Blueprint Medicines
BPMC
| $13.9M | ﹤0.01% |
134,883
-400,563
| -75% | -$37.3M |
|
2512
Thor Industries
THO
$4.16B
| $13.8M | ﹤0.01% |
112,790
-42,685
| -27% | -$4.87M |
|
2513
First Majestic Silver
AG
$8.13B
| $13.8M | ﹤0.01% |
1,225,234
-326,652
| -21% | -$4.22M |
|
2514
Century Aluminum
CENX
$4.66B
| $13.8M | ﹤0.01% |
1,029,088
-870,702
| -46% | -$10.9M |
|
2515
Curtiss-Wright
CW
$28B
| $13.8M | ﹤0.01% |
109,701
+1,948
| +2% | +$233K |
|
2516
Liberty Global Class A
LBTYA
$3.72B
| $13.8M | ﹤0.01% |
464,014
+250,853
| +118% | +$6.96M |
|
2517
United Bankshares
UBSI
$6.76B
| $13.8M | ﹤0.01% |
380,005
-184,424
| -33% | -$6.45M |
|
2518
First Trust Dorsey Wright Momentum & Low Volatility ETF
DVOL
$74.2M
| $13.8M | ﹤0.01% |
501,566
-53,488
| -10% | -$1.53M |
|
2519
Haemonetics
HAE
$3.88B
| $13.8M | ﹤0.01% |
195,356
-492,997
| -72% | -$31.1M |
|
2520
FuboTV Inc
FUBO
$281M
| $13.8M | ﹤0.01% |
47,951
+17,487
| +57% | +$5.72M |
|
2521
Advanced Energy
AEIS
$13.7B
| $13.8M | ﹤0.01% |
156,974
-20,375
| -11% | -$1.91M |
|
2522
Applied Industrial Technologies
AIT
$13.2B
| $13.8M | ﹤0.01% |
152,702
-35,923
| -19% | -$3.16M |
|
2523
Hess Midstream
HESM
$5.17B
| $13.8M | ﹤0.01% |
487,582
-48,763
| -9% | -$1.24M |
|
2524
JPMorgan BetaBuilders MSCI US REIT ETF
BBRE
$1.27B
| $13.7M | ﹤0.01% |
142,926
-3,765
| -3% | -$377K |
|
2525
Xtrackers MSCI Japan Hedged Equity ETF
DBJP
$689M
| $13.7M | ﹤0.01% |
271,334
-339
| -0.1% | -$16.7K |
|
Similar funds
Morgan Stanley's Q3 2021 Portfolio in Review
As of Q3 2021, Morgan Stanley held 8,301 positions worth $742B, down 2.1% from $758B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Morgan Stanley's Q3 2021 filing shows 450 new, 3,451 increased, 3,332 reduced and 228 closed positions. Its largest new stake was Ginkgo Bioworks: 281,861 shares worth $131M. The largest sale was Alphabet (Google) Class C, an estimated $2.32B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Morgan Stanley's largest Q3 2021 buy was Ginkgo Bioworks: 281,861 shares worth $131M.
- Morgan Stanley added most to Coupang in Q3 2021, an estimated $1.83B increase.
- Morgan Stanley's biggest Q3 2021 reduction was Alphabet (Google) Class C, cutting an estimated $2.32B.
- Morgan Stanley fully exited Proofpoint, Inc. in Q3 2021, selling an estimated $441M.
- Morgan Stanley's ten largest holdings make up 15% of its $742B portfolio in Q3 2021.
- Morgan Stanley opened 450 new positions and closed 228 in Q3 2021.
- Morgan Stanley's portfolio value fell 2.1% quarter-over-quarter to $742B.
Based on Morgan Stanley's 13F filing for Q3 2021, filed 15 Nov 2021.